GlassScriptPhysician profile
Nicholas James Westfall
NPI 1538458575
$59,028.55
in general payments reported to CMS, 2019-2025
38 companies · $19K in 2025
The $19K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $706 · 2020: $11K · 2021: $12K · 2022: $8,022 · 2023: $3,770 · 2024: $4,730 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $9,825 · Travel and Lodging: $6,498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,280.00 |
| Food and Beverage | $9,824.99 |
| Travel and Lodging | $6,497.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Swan Valley Medical Incorporated | $14,978.07 | 2021-2024 | |
| Olympus America INC. | $13,486.83 | 2019-2025 | Bovie, Uretero-Reno Fiberscope, Uropass |
| Intuitive Surgical, INC. | $13,049.85 | 2020-2024 | Da Vinci Surgical System |
| Boston Scientific Corporation | $4,163.40 | 2019-2025 | General - Kidney Stone Disease, Ams 700, Spaceoar Vue System - 10ml |
| Procept Biorobotics Corporation | $3,157.53 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Axonics, INC. | $1,885.67 | 2021-2024 | Bulkamid, Axonics |
| Coloplast Corp | $1,579.85 | 2021-2025 | |
| Arthrex, INC. | $1,441.45 | 2021 | |
| Valencia Technologies Corporation | $1,043.58 | 2022-2025 | Ecoin Device Kit |
| Stryker Corporation | $882.19 | 2025 | 1788 |
| Teleflex LLC | $836.63 | 2021-2025 | Urolift, Barrigel |
| Laborie Medical Technologies Corp. | $308.67 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Caldera Medical, INC | $307.09 | 2021 | |
| Neotract INC. | $263.49 | 2019-2020 | |
| Astellas Pharma US INC | $257.19 | 2019-2025 | Xtandi, Myrbetriq |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $240.54 | 2021-2023 | Interstim |
| Urogen Pharma, INC. | $155.28 | 2021 | |
| Bluewind Medical | $113.22 | 2024 | Revi |
| Histosonics, INC. | $108.42 | 2025 | |
| Sumitomo Pharma America, INC. | $94.88 | 2023-2025 | Orgovyx, Gemtesa |
| Progenics Pharmaceuticals, INC. | $92.21 | 2023-2024 | Pylarify |
| Convatec INC. | $67.53 | 2021-2022 | |
| Palette Life Sciences, INC. | $65.04 | 2022 | |
| Karl Storz Lithotripsy-America | $64.93 | 2019 | |
| Calyxo, INC. | $60.74 | 2025 | Cvac Aspiration System |
| Bayer Healthcare Pharmaceuticals INC. | $40.59 | 2021-2025 | |
| Pfizer INC. | $37.26 | 2023 | |
| Innovation Technologies INC | $36.67 | 2025 | Irrisept |
| Telix Pharmaceuticals | $31.42 | 2024 | Illuccix |
| Myovant Sciences INC. | $30.84 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $26.53 | 2024 | Keytruda, Welireg |
| Xeris Pharmaceuticals, INC. | $24.99 | 2025 | Gvoke Hypopen |
| Abbvie INC. | $18.05 | 2020 | |
| Ferring Pharmaceuticals INC. | $17.88 | 2025 | Adstiladrin |
| Endo Pharmaceuticals INC. | $16.39 | 2023 | Xiaflex |
| Becton, Dickinson and Company | $15.63 | 2024 | Bard Urinary Drainage Bag |
| Sun Pharmaceutical Industries INC. | $14.20 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $13.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$0.05 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Westfall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.